The December 2024 issue of Toxicological Sciences includes an Editoral that thanks the volunteer service of experts who conducted peer reviews for ToxSci in 2024. A Contemporary Review covers epidemiological, animal, and cell studies on PM2.5 exposure and bone health, as well as studies on PM2.5-induced diseases with skeletal complications, while an In-Depth Review centers on the evolution of RAS inhibitors in cancer therapy, delving into the common adverse effects associated with these inhibitors, their underlying mechanisms, and the potential strategies for mitigation. Additionally, two #ToxSpotlight articles are featured: One highlights a pharmacokinetic analysis of nicotine and its metabolites in male Sprague-Dawley rats following nose-only inhalation, oral gavage, and intravenous infusion of nicotine while the other discusses the hemolytic toxicity tapestry of peptides using chemical space complex networks.